Fate Therapeutics Inc.

NASDAQ: FATE · Real-Time Price · USD
1.09
0.02 (1.87%)
At close: Aug 15, 2025, 3:59 PM
1.11
1.37%
After-hours: Aug 15, 2025, 05:33 PM EDT

Fate Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-186.26M -160.93M -281.72M -212.15M
Depreciation & Amortization
18.96M 18.28M 13.76M 5.85M
Stock-Based Compensation
41.5M 43.46M 78.73M 54.36M
Other Working Capital
816K 11.47M -19.16M 5.26M
Other Non-Cash Items
4.89M -52.26M -24.27M -18.1M
Deferred Income Tax
n/a n/a n/a 5.07M
Change in Working Capital
-1.96M 19.18M -34.71M 2.1M
Operating Cash Flow
-122.87M -132.26M -248.21M -162.87M
Capital Expenditures
-730K -6.15M -35.57M -50.7M
Cash Acquisitions
n/a n/a -202.32M 273.32M
Purchase of Investments
-317.75M -358.81M -404.8M -968.16M
Sales Maturities Of Investments
330.7M 477.63M 607.11M 694.84M
Other Investing Acitivies
n/a n/a 202.32M -273.32M
Investing Cash Flow
12.22M 112.67M 166.75M -324.02M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
25.36M n/a n/a 41.39M
Financial Cash Flow
99.89M 85K 9.21M 453.13M
Net Cash Flow
-10.76M -19.51M -72.25M -33.76M
Free Cash Flow
-123.6M -138.42M -283.77M -213.57M